These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. An "Fc-Silenced" IgG1 Format With Extended Half-Life Designed for Improved Stability. Borrok MJ; Mody N; Lu X; Kuhn ML; Wu H; Dall'Acqua WF; Tsui P J Pharm Sci; 2017 Apr; 106(4):1008-1017. PubMed ID: 28057542 [TBL] [Abstract][Full Text] [Related]
23. The Structural Role of Antibody N-Glycosylation in Receptor Interactions. Subedi GP; Barb AW Structure; 2015 Sep; 23(9):1573-1583. PubMed ID: 26211613 [TBL] [Abstract][Full Text] [Related]
24. Physical stability comparisons of IgG1-Fc variants: effects of N-glycosylation site occupancy and Asp/Gln residues at site Asn 297. Alsenaidy MA; Okbazghi SZ; Kim JH; Joshi SB; Middaugh CR; Tolbert TJ; Volkin DB J Pharm Sci; 2014 Jun; 103(6):1613-1627. PubMed ID: 24740840 [TBL] [Abstract][Full Text] [Related]
25. Effects of Glycan Structure on the Stability and Receptor Binding of an IgG4-Fc. Kang H; Larson NR; White DR; Middaugh CR; Tolbert T; Schöneich C J Pharm Sci; 2020 Jan; 109(1):677-689. PubMed ID: 31669606 [TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of IgG1 with asymmetrical Fc glycosylation. Ha S; Ou Y; Vlasak J; Li Y; Wang S; Vo K; Du Y; Mach A; Fang Y; Zhang N Glycobiology; 2011 Aug; 21(8):1087-96. PubMed ID: 21470983 [TBL] [Abstract][Full Text] [Related]
28. Correlating the Impact of Well-Defined Oligosaccharide Structures on Physical Stability Profiles of IgG1-Fc Glycoforms. More AS; Toprani VM; Okbazghi SZ; Kim JH; Joshi SB; Middaugh CR; Tolbert TJ; Volkin DB J Pharm Sci; 2016 Feb; 105(2):588-601. PubMed ID: 26869421 [TBL] [Abstract][Full Text] [Related]
29. Abolition of aggregation of CH Oyama K; Ohkuri T; Ochi J; Caaveiro JMM; Ueda T Biochem Biophys Res Commun; 2021 Jun; 558():114-119. PubMed ID: 33915325 [TBL] [Abstract][Full Text] [Related]
30. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. Krapp S; Mimura Y; Jefferis R; Huber R; Sondermann P J Mol Biol; 2003 Jan; 325(5):979-89. PubMed ID: 12527303 [TBL] [Abstract][Full Text] [Related]
31. H NMR studies of the Fc region of human IgG1 and IgG3 immunoglobulins: assignment of histidine resonances in the CH3 domain and identification of IgG3 protein carrying G3m(st) allotypes. Shimizu A; Honzawa M; Ito S; Miyazaki T; Matsumoto H; Nakamura H; Michaelsen TE; Arata Y Mol Immunol; 1983 Feb; 20(2):141-8. PubMed ID: 6843552 [TBL] [Abstract][Full Text] [Related]
32. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis. Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848 [TBL] [Abstract][Full Text] [Related]
33. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mimura Y; Church S; Ghirlando R; Ashton PR; Dong S; Goodall M; Lund J; Jefferis R Mol Immunol; 2000; 37(12-13):697-706. PubMed ID: 11275255 [TBL] [Abstract][Full Text] [Related]
34. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life. Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD MAbs; 2015; 7(1):84-95. PubMed ID: 25524268 [TBL] [Abstract][Full Text] [Related]
35. Increased aggregation propensity of IgG2 subclass over IgG1: role of conformational changes and covalent character in isolated aggregates. Franey H; Brych SR; Kolvenbach CG; Rajan RS Protein Sci; 2010 Sep; 19(9):1601-15. PubMed ID: 20556807 [TBL] [Abstract][Full Text] [Related]
36. An atomistic perspective on antibody-dependent cellular cytotoxicity quenching by core-fucosylation of IgG1 Fc N-glycans from enhanced sampling molecular dynamics. Harbison A; Fadda E Glycobiology; 2020 May; 30(6):407-414. PubMed ID: 31829411 [TBL] [Abstract][Full Text] [Related]
37. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. Matsumiya S; Yamaguchi Y; Saito J; Nagano M; Sasakawa H; Otaki S; Satoh M; Shitara K; Kato K J Mol Biol; 2007 May; 368(3):767-79. PubMed ID: 17368483 [TBL] [Abstract][Full Text] [Related]
38. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. Ionescu RM; Vlasak J; Price C; Kirchmeier M J Pharm Sci; 2008 Apr; 97(4):1414-26. PubMed ID: 17721938 [TBL] [Abstract][Full Text] [Related]
39. Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry. Houde D; Arndt J; Domeier W; Berkowitz S; Engen JR Anal Chem; 2009 Apr; 81(7):2644-51. PubMed ID: 19265386 [TBL] [Abstract][Full Text] [Related]
40. Comparative Evaluation of the Chemical Stability of 4 Well-Defined Immunoglobulin G1-Fc Glycoforms. Mozziconacci O; Okbazghi S; More AS; Volkin DB; Tolbert T; Schöneich C J Pharm Sci; 2016 Feb; 105(2):575-587. PubMed ID: 26869420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]